Key facts
- This page summarizes John Maraganore's Form 5 filing for AGIOS PHARMACEUTICALS, INC. (AGIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2023, 15:06.
John Maraganore - 31 Dec 2022 Form 5 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Reporting relationship
- Director
- Issuer ticker
- AGIO
- Reported as of
- 31 Dec 2022
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 03 Feb 2023, 15:06:03 UTC
- Prior SEC filing
- 02 Sep 2022
- Next SEC filing
- 08 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Cook, as Attorney-in-fact for John Maraganore
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Maraganore filed Form 5 for AGIOS PHARMACEUTICALS, INC. (AGIO) on 03 Feb 2023.
Change
- Previous filing in this sequence was filed on 02 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGIO
transaction
Common stock
Gift
- Transaction value
- $0
- Shares
- -1,500
- Change %
- -5%
- Price
- $0.000000
- Shares after
- 28,528
- Date
- 20 Sep 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This disposition reflects a bona fide gift of 1,500 shares to charity.